AR043063A1 - Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas - Google Patents
Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricasInfo
- Publication number
- AR043063A1 AR043063A1 ARP030104544A ARP030104544A AR043063A1 AR 043063 A1 AR043063 A1 AR 043063A1 AR P030104544 A ARP030104544 A AR P030104544A AR P030104544 A ARP030104544 A AR P030104544A AR 043063 A1 AR043063 A1 AR 043063A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkoxy
- alkyl
- hydroxy
- hydrogen
- alkoxycarbonyl
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 19
- 125000000217 alkyl group Chemical group 0.000 abstract 17
- 239000001257 hydrogen Substances 0.000 abstract 16
- 229910052739 hydrogen Inorganic materials 0.000 abstract 16
- 150000002431 hydrogen Chemical class 0.000 abstract 15
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 10
- 229910052736 halogen Inorganic materials 0.000 abstract 10
- 150000002367 halogens Chemical group 0.000 abstract 10
- 125000003545 alkoxy group Chemical group 0.000 abstract 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 9
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 8
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 abstract 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 6
- -1 piperidino, piperazino Chemical group 0.000 abstract 5
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 abstract 4
- 125000003282 alkyl amino group Chemical group 0.000 abstract 4
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 3
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 2
- 125000004104 aryloxy group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 2
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 abstract 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 abstract 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 abstract 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 1
- FJRPOHLDJUJARI-UHFFFAOYSA-N 2,3-dihydro-1,2-oxazole Chemical compound C1NOC=C1 FJRPOHLDJUJARI-UHFFFAOYSA-N 0.000 abstract 1
- SCEVBRBKKQZTKM-UHFFFAOYSA-N 5-[[6-chloro-5-(1-methylindol-5-yl)-1H-benzimidazol-2-yl]oxy]-N-hydroxy-2-methylbenzamide Chemical compound ClC=1C(=CC2=C(NC(=N2)OC=2C=CC(=C(C(=O)NO)C=2)C)C=1)C=1C=C2C=CN(C2=CC=1)C SCEVBRBKKQZTKM-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 abstract 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- AXLOCHLTNQDFFS-BESJYZOMSA-N azastene Chemical compound C([C@H]1[C@@H]2CC[C@@]([C@]2(CC[C@@H]1[C@@]1(C)C2)C)(O)C)C=C1C(C)(C)C1=C2C=NO1 AXLOCHLTNQDFFS-BESJYZOMSA-N 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 150000003536 tetrazoles Chemical class 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Reivindicación 1: Un compuesto caracterizado por la fórmula (1) donde R1 es hidrógeno, alquilo C1-4, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-4, alcoxi C1-4, alcoxi C1-4-alquilo C1-4, alcoxicarbonilo C1-4, alquenilo C2-4, alquinilo C2-4, fluoro-alquilo C1-4, hidroxi-alquilo C1-4, mono- o di-alquilamino C1-4 o alquilcarboniloxi C1-4-alquilo C1-4, R2 es hidrógeno, alquilo C1-4, arilo, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-4, alcoxicarbonilo C1-4, mono- o di-alquilamino C1-4 alquilcarbonilo C1-4, hidroxi-alquilo C1-4, fluoro-alquilo C2-4, aril-alcoxi C1-4-alquilo C1-4, hidroxi o alcoxi C1-4, R3 es hidrógeno, halógeno, fluoro-alquilo C1-4, carboxilo,-CO-alcoxi C1-4, hidroxi-alquilo C1-4, alcoxi C1-4-alquilo C1-4,alcoxi C1-4-alcoxi C1-4-alquilo C1-4, fluoro-alcoxi C1-4-alquilo C1-4, ciano, el grupo -CO-NR31R32, el grupo SO2-NR31R32 o el grupo Het, donde R31 es hidrógeno, hidroxilo, alquilo C1-7, hidroxi-alquilo C1-4, alcoxi C1-4-alquilo C1-4 o cicloalquilo C3-7, amino y R32 es hidrógeno, alquilo C1-7, hidroxi-alquilo C1-4 o alcoxi C1-4-alquilo C1-4, o donde R31 y R32 tomados conjuntamente, incluyendo el átomo de nitrógeno al cual están ligados, son un grupo pirrolidino, piperidino, piperazino, N-alquil C1-4piperazino, morfolino, aziridino o azetidino y Het es un residuo heterocíclico, substituido por R33, R34 y R35, seleccionado del grupo formado por oxadiazol, dihidro-oxazol, dihidroimidazol, oxazol, imidazol, isoxazol, dihidroisoxazol, pirazol y tetrazol; donde R33 es hidrógeno, alquilo C1-4, hidroxi-alquilo C1-4, alcoxi C1-4, alqueniloxi C2-4, alquilcarbonilo C1-4, carboxi, alcoxicarbonilo C1-4, carboxi-alquilo C1-4, alcoxicarbonil C1-4-alquilo C1-4, halógeno, hidroxi, arilo, aril-alquilo C1-4, ariloxi, aril-alcoxi C1-4, trifluorometilo, nitro, amino, mono- o di-alquil C1-4amino, alquil C1-4carbonilamino, alcoxi C1-4carbonilamino, alcoxi C1-4-alcoxi C1-4carbonilamino o sulfonilo, R34 es hidrógeno, alquilo C1-4, alcoxi C1-4, alcoxicarbonilo C1-4, halógeno, trifluorometilo o hidroxi, R35 es hidrógeno, alquilo C1-4, alcoxi C1-4, alcoxicarbonilo C1-4, halógeno, trifluorometilo o hidroxi, X es O (oxígeno) o NH e Y tiene el significado -CH2-Ar donde Ar es un residuo aromático mono- o bicíclico, substituido por R4, R5, R6 y R7, que es seleccionado del grupo formado por fenilo, naftilo, pirrolilo, pirazolilo, imidazolilo, 1,2,3-triazolilo, indolilo, benzimidazolilo, furilo, benzofurilo, tienilo, benzotienilo, tiazolilo, isoxazolilo, piridinilo, pirimidinilo, quinolinilo y isoquinolinilo, o Y significa el radical (2) donde Z tiene el significado -CHR8- o -CHR8-CHR9- donde en Ar y/o en el radical (2) R4 es hidrógeno, alquilo C1-4, hidroxi-alquilo C1-4, alcoxi C1-4, alqueniloxi C2-4, alquilcarbonilo C1-4, carboxi, alcoxicarbonilo C1-4,carboxi-alquilo C1-4, alcoxicarbonil C1-4-alquilo C1-4, halógeno, hidroxi, arilo, aril-alquilo C1-4, ariloxi, aril-alcoxi C1-4, trifluorometilo, nitro, amino, mono- o di-alquil C1-4amino, alquil C1-4carbonilamino, alcoxi C1-4carbonilamino, alcoxi C1-4-alcoxi C1-4carbonilamino o sulfonilo, R5 es hidrógeno, alquilo C1-4, alcoxi C1-4, alcoxicarbonilo C1-4, halógeno, trifluorometilo o hidroxi, R6 es hidrógeno, alquilo C1-4 o halógeno y R7 es hidrógeno, alquilo C1-4 o halógeno, R8 es hidrógeno, alquilo C1-4, alquenilo C2-7, hidroxilo, alcoxi C1-4, alcoxi C1-4 oxo-substituido, cicloalcoxi C3-7, cicloalquil C3-7-alcoxi C1-4, hidroxi-alcoxi C1-4, alcoxi C1-4-alcoxi C1-4, alcoxi C1-4-alcoxi C1-4-alcoxi C1-4, cicloalcoxi C3-7-alcoxi C1-4, cicloalquil C3-7-alcoxi C1-4-alcoxi C1-4, alquilcarboniloxi C1-4, halo-alcoxi C1-4, amino, mono- o di-alquilamino C1-4, alquilcarbonilamino C1-4, alcoxi C1-4carbonilamino, mono- o di-alquil C1-4amino-alquil C1-4carboniloxi, alcoxi C1-4-alcoxi C1-4carbonilamino o alcoxi C1-4-alquil C1-4carboniloxi, R9 es hidrógeno, alquilo C1-7, alquenilo C2-7, hidroxilo, alcoxi C1-4, alcoxi C1-4 oxo-substituido, cicloalcoxi C3-7, cicloalquil C3-7-alcoxi C1-4, hidroxi-alcoxi C1-4, alcoxi C1-4-alcoxi C1-4, alcoxi C1-4-alcoxi C1-4-alcoxi C1-4, cicloalcoxi C3-7-alcoxi C1-4, cicloalquil C3-7-alcoxi C1-4-alcoxi C1-4, alquilcarboniloxi C1-4, halo-alcoxi C1-4, amino, mono- o di-alquilamino C1-4, alquilcarbonilamino C1-4, alcoxicarbonilamino C1-4, mono- o di-alquilamino C1-4-alquilcarboniloxi C1-4, alcoxi C1-4-alcoxicarbonilamino C1-4 o alcoxi C1-4-alquilcarboniloxi C1-4, y donde arilo es fenilo o fenilo substituido por uno, dos o tres substituyentes iguales o diferentes del grupo formado por alquilo C1-4, alcoxi C1-4, carboxi, alcoxicarbonilo C1-4, halógeno, trifluorometilo, nitro, trifluorometoxi, hidroxi y ciano, con la condición de que R3 no tiene el significado de hidrógeno o halógeno cuando Y significa -CH2-Ar y R2 significa hidrógeno, alquilo o cicloalquil-alquilo, o una sal del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02027874 | 2002-12-13 | ||
| EP03021348 | 2003-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043063A1 true AR043063A1 (es) | 2005-07-13 |
Family
ID=32598782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030104544A AR043063A1 (es) | 2002-12-13 | 2003-12-10 | Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060194969A1 (es) |
| EP (1) | EP1575924A1 (es) |
| JP (1) | JP2006511600A (es) |
| KR (1) | KR20050084170A (es) |
| AR (1) | AR043063A1 (es) |
| AU (1) | AU2003294831A1 (es) |
| BR (1) | BR0317041A (es) |
| CA (1) | CA2508838A1 (es) |
| CO (1) | CO5580786A2 (es) |
| EA (1) | EA008779B1 (es) |
| HR (1) | HRP20050612A2 (es) |
| IS (1) | IS7926A (es) |
| MX (1) | MXPA05006052A (es) |
| NO (1) | NO20053242L (es) |
| NZ (1) | NZ540862A (es) |
| PL (1) | PL375820A1 (es) |
| RS (1) | RS20050435A (es) |
| TW (1) | TW200504031A (es) |
| WO (1) | WO2004054984A1 (es) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004226180A1 (en) | 2003-04-04 | 2004-10-14 | Altana Pharma Ag | Cyclic benzimidazoles |
| AR049168A1 (es) * | 2004-05-18 | 2006-07-05 | Altana Pharma Ag | Derivados de benzimidazol |
| CA2589448A1 (en) * | 2004-12-09 | 2006-06-15 | Altana Pharma Ag | Substituted imidazo[4,5-b]pyridines as inhibitors of gastric acid secretion |
| JP2008534475A (ja) * | 2005-03-24 | 2008-08-28 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | ６−チアミド置換されたベンゾイミダゾール |
| ES2332534T3 (es) | 2005-06-14 | 2010-02-08 | Raqualia Pharma Inc | Derivados de bencimidazol sustituidos con cromano como antagonistas de la bomba de acidos. |
| AR057061A1 (es) * | 2005-06-16 | 2007-11-14 | Altana Pharma Ag | Espiro-bencimidazoles farmaceuticamente activos y su uso en la fabricacion de medicamentos |
| CA2619518A1 (en) * | 2005-08-22 | 2007-03-01 | Nycomed Gmbh | Isotopically substituted benzimidazole derivatives |
| WO2007031860A1 (en) * | 2005-09-15 | 2007-03-22 | Pfizer Japan Inc. | Indane substituted benzimidazoles and their use as acid pump inhibitors |
| WO2007072146A1 (en) * | 2005-12-19 | 2007-06-28 | Pfizer Japan Inc. | Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| WO2007072142A2 (en) * | 2005-12-19 | 2007-06-28 | Pfizer Japan Inc. | Benzimidazole-5-carboxamide derivatives |
| WO2008017466A1 (en) * | 2006-08-08 | 2008-02-14 | Nycomed Gmbh | Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives |
| RU2412188C2 (ru) | 2006-09-21 | 2011-02-20 | Раквалиа Фарма Инк. | Производные бензимидазола в качестве селективных ингибиторов кислотной помпы |
| WO2008071765A1 (en) * | 2006-12-14 | 2008-06-19 | Nycomed Gmbh | Pharmaceutically active spiro-substituted benzimidazole derivatives |
| WO2008084067A2 (en) * | 2007-01-12 | 2008-07-17 | Nycomed Gmbh | Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives |
| WO2008151927A2 (en) * | 2007-06-15 | 2008-12-18 | Nycomed Gmbh | 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| CN101801189B (zh) | 2007-08-27 | 2015-08-26 | 基内塔第四有限责任公司 | 用于治疗沙粒病毒感染的抗病毒药 |
| WO2010081670A2 (en) * | 2009-01-14 | 2010-07-22 | Lonza Ltd | Process for the preparation of benzimidazoles |
| CN102470126A (zh) | 2009-07-09 | 2012-05-23 | 拉夸里亚创药株式会社 | 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂 |
| WO2012081036A2 (en) * | 2010-12-13 | 2012-06-21 | Sequent Scientific Limited | A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione) |
| RU2506259C1 (ru) * | 2012-12-04 | 2014-02-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный университет им. П.Г. Демидова" | Способ получения 4-{4-амино-2-хлоро-5-[(5-хлоро-2-метил-1н-бензимидазол-6-ил)амино]фенокси}бензойной кислоты |
| EP2953950B1 (en) | 2013-02-11 | 2021-01-13 | The Regents of The University of California | Compositions and methods for treating neurodegenerative diseases |
| BR112015031073B1 (pt) | 2013-06-21 | 2022-11-29 | Zenith Epigenetics Ltd | Compostos inibidores bicíclicos de bromodomínio e composição farmacêutica contendo os referidos compostos |
| US9636328B2 (en) | 2013-06-21 | 2017-05-02 | Zenith Epigenetics Ltd. | Substituted bicyclic compounds as bromodomain inhibitors |
| KR101472686B1 (ko) | 2013-07-09 | 2014-12-16 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 제조방법 |
| KR20160038008A (ko) | 2013-07-31 | 2016-04-06 | 제니쓰 에피제네틱스 코포레이션 | 브로모도메인 억제제로서 신규 퀴나졸리논 |
| US10710992B2 (en) | 2014-12-01 | 2020-07-14 | Zenith Epigenetics Ltd. | Substituted pyridinones as bromodomain inhibitors |
| WO2016092375A1 (en) | 2014-12-11 | 2016-06-16 | Zenith Epigenetics Corp. | Substituted heterocycles as bromodomain inhibitors |
| US10231953B2 (en) | 2014-12-17 | 2019-03-19 | Zenith Epigenetics Ltd. | Inhibitors of bromodomains |
| KR101684053B1 (ko) | 2015-01-20 | 2016-12-08 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 신규 결정형 및 이의 제조방법 |
| EP3305291B1 (en) * | 2015-06-08 | 2021-05-19 | HK inno.N Corporation | Uses of benzimidazole derivative for nocturnal acid breakthrough |
| CA3067695A1 (en) | 2017-06-21 | 2018-12-27 | Mitokinin, Inc. | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
| CN113527272B (zh) * | 2021-08-06 | 2023-07-21 | 西安淳甄新材料有限公司 | 一种特戈拉赞的合成方法 |
| KR20230099093A (ko) | 2021-12-27 | 2023-07-04 | 에이치케이이노엔 주식회사 | 벤즈이미다졸 유도체의 제조방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8604566D0 (sv) * | 1986-10-27 | 1986-10-27 | Haessle Ab | Novel compunds |
| IL108520A (en) * | 1993-02-15 | 1997-09-30 | Byk Gulden Lomberg Chem Fab | 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| SE9602286D0 (sv) * | 1996-06-10 | 1996-06-10 | Astra Ab | New compounds |
-
2003
- 2003-12-10 AR ARP030104544A patent/AR043063A1/es unknown
- 2003-12-11 JP JP2005502432A patent/JP2006511600A/ja active Pending
- 2003-12-11 PL PL03375820A patent/PL375820A1/xx not_active Application Discontinuation
- 2003-12-11 WO PCT/EP2003/014069 patent/WO2004054984A1/en active Application Filing
- 2003-12-11 EA EA200500895A patent/EA008779B1/ru not_active IP Right Cessation
- 2003-12-11 EP EP03785790A patent/EP1575924A1/en not_active Withdrawn
- 2003-12-11 NZ NZ540862A patent/NZ540862A/en unknown
- 2003-12-11 AU AU2003294831A patent/AU2003294831A1/en not_active Abandoned
- 2003-12-11 KR KR1020057010166A patent/KR20050084170A/ko not_active Application Discontinuation
- 2003-12-11 RS YUP-2005/0435A patent/RS20050435A/sr unknown
- 2003-12-11 BR BR0317041-1A patent/BR0317041A/pt unknown
- 2003-12-11 MX MXPA05006052A patent/MXPA05006052A/es active IP Right Grant
- 2003-12-11 CA CA002508838A patent/CA2508838A1/en not_active Abandoned
- 2003-12-11 US US10/537,693 patent/US20060194969A1/en not_active Abandoned
- 2003-12-12 TW TW092135239A patent/TW200504031A/zh unknown
-
2005
- 2005-07-01 NO NO20053242A patent/NO20053242L/no not_active Application Discontinuation
- 2005-07-01 HR HR20050612A patent/HRP20050612A2/xx not_active Application Discontinuation
- 2005-07-01 IS IS7926A patent/IS7926A/is unknown
- 2005-07-11 CO CO05067806A patent/CO5580786A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ540862A (en) | 2008-07-31 |
| PL375820A1 (en) | 2005-12-12 |
| TW200504031A (en) | 2005-02-01 |
| NO20053242D0 (no) | 2005-07-01 |
| RS20050435A (en) | 2007-08-03 |
| KR20050084170A (ko) | 2005-08-26 |
| BR0317041A (pt) | 2005-10-25 |
| HRP20050612A2 (en) | 2006-08-31 |
| AU2003294831A1 (en) | 2004-07-09 |
| JP2006511600A (ja) | 2006-04-06 |
| EA008779B1 (ru) | 2007-08-31 |
| WO2004054984A1 (en) | 2004-07-01 |
| EA200500895A1 (ru) | 2005-12-29 |
| MXPA05006052A (es) | 2005-08-18 |
| NO20053242L (no) | 2005-07-01 |
| IS7926A (is) | 2005-07-01 |
| US20060194969A1 (en) | 2006-08-31 |
| CA2508838A1 (en) | 2004-07-01 |
| CO5580786A2 (es) | 2005-11-30 |
| EP1575924A1 (en) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR043063A1 (es) | Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas | |
| AR050970A1 (es) | Pirimidinas 5-sustituidas con carbociclos o heterociclos inhibidoras del vih; composiciones farmaceuticas que las contienen y uso de las mismas como medicamentos. | |
| AR038703A1 (es) | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 | |
| AR055592A1 (es) | Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace) | |
| AR057810A1 (es) | Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo y composicion farmaceutica | |
| PE20160751A1 (es) | Moduladores de tetrahidropiridopirazinas de gpr6 | |
| AR056445A1 (es) | Derivados arilicos y heteroarilicos de 6 miembros para tratar virus | |
| AR084588A1 (es) | Compuesto heterociclico fusionado y su uso para el control de plagas | |
| AR015269A1 (es) | Compuesto amidinico y composicion farmaceutica, inhibidor de la coagulacion sanguinea e inhibidor del factor xa que lo comprenden | |
| AR062928A1 (es) | Inhibidores de la actividad quinasa utiles en el tratamiento de trastornos mediados por mecanismos de ikk2 | |
| CO6220911A2 (es) | Composicion herbicida que comprende derivados de isoxazolinma como ingredientes activos | |
| EA200970461A1 (ru) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ | |
| HRP20100283T8 (en) | Derivatives of n-' (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity | |
| TW200716531A (en) | Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia | |
| AR037754A1 (es) | Herbicidas | |
| PE20130244A1 (es) | Inhibidores del virus de la hepatitis c | |
| AR056536A1 (es) | Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace) | |
| CL2004000076A1 (es) | Compuestos derivados de indol, inhibidores de polimerasa, sales; composicion farmaceutica que los comprende; procedimiento de preparacion de dichos compuestos; compuestos intermediarios; y uso del compuesto para tratar una infeccion causada por el vi | |
| AR073586A1 (es) | Compuestos heterociclicos utiles para el tratamiento de vhc | |
| DOP2010000046A (es) | Compuestos de biciclolactama sustituida | |
| AR039540A1 (es) | Compuestos microbicidas con contenido de pirimidina o triazina | |
| PE20070808A1 (es) | COMPUESTOS DERIVADOS DE ISOQUINOLINA COMO INHIBIDORES DE Rho-QUINASA | |
| HRP20090151T3 (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
| AR072149A1 (es) | Derivados de heteroaril-carboxamida | |
| AR054272A1 (es) | Derivados de 3- aminopirrilidinas tri, tetra - sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |